Profile
Liliana Bar worked as a Director of Development & Base Business Unit at OMRIX Biopharmaceuticals, Inc. She then worked as Vice President of Research & Development at Kamada Ltd.
from 2012 to 2019.
Dr. Bar received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Former positions of Liliana Bar
| Companies | Position | End |
|---|---|---|
| KAMADA LTD. | Chief Tech/Sci/R&D Officer | 2019-01-31 |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | - |
Training of Liliana Bar
| The Hebrew University of Jerusalem | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KAMADA LTD. | Health Technology |
| Private companies | 1 |
|---|---|
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
- Stock Market
- Insiders
- Liliana Bar
